Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen

Status Recruiting

Clinical Trial Summary

The lichen planus is a mucocutaneous disease of unknown etiology with an incidence of 1-2%, that affects in 30-70% of cases either the mucosa of the mouth, or partly in combination with infection of the skin, the oral with his known premalignant potential in up to 2-3% predisposed to the development of an oral squamous cell carcinoma.In rare cases, there is also an manifestation of the lining of the esophagus, which can then be associated with symptomatic strictures of the esophagus.

The value of moreover increasingly established endoscopic imaging procedures are investigated as well as data of the natural long-term outcome in esophageal lichen planus infestation especially in view of malignant transformation.

Clinical Trial Description

The lichen planus is a mucocutaneous disease of unknown etiology that manifests itself with an incidence of 1-2% in 30-70% of cases either at the mucosa of the mouth, or partly in combination with infection of the skin, the oral with his known premalignant potential in up to 2-3% predisposed to the development of an oral squamous cell carcinoma. In rare cases, there is also an manifestation of the lining of the esophagus, which can then be associated with symptomatic strictures of the esophagus. In addition, four cases have been reported with esophageal squamous cell carcinoma in patients with esophageal lichen planus.

The value of moreover increasingly established use of narrow-band imaging (a process for improving the detection of early cancers in the gastrointestinal tract by creating a maximum contrast between outright and altered mucosa, which could have already shown an improved detection rate of early lesions of the esophagus as well as squamous cell carcinoma), or the chromoendoscopy has means for example Lugol solution in correlation to the histopathologic findings in lichen planus), has not been investigated to date.

Also, data of the natural long-term outcome in esophageal lichen planus infestation especially in view of malignant transformation are currently not available. ;

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02532166
Study type	Interventional
Source	Ruhr University of Bochum
Contact	Andrea Riphaus, PD MD
Phone	0049 511 8208
Email	ariphaus@web.de
Status	Recruiting
Phase	N/A
Start date	January 2012
Completion date	December 2016

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06021405` - Koebner's Phenomenon in Psoriasis and Lichen Planus	N/A
Recruiting	`NCT03340155` - Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases	N/A
Completed	`NCT05787925` - Adjunctive Oral Systemic Vitamin E Therapy on Salivary Nitric Oxide Level in Patients With Erosive Oral Lichen Planus	N/A
Completed	`NCT03630198` - Pain Outcomes Following Intralesional Corticosteroid Injections	Phase 4
Completed	`NCT04952961` - Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study	N/A
Recruiting	`NCT04697563` - Laser Therapy in Women With Lichenoid Disorders	N/A
Recruiting	`NCT06451744` - Cellular and Molecular Biomarkers in Patients With Lichen Planus	N/A
Completed	`NCT03265093` - Use of Injectable Platelet Rich Fibrin in Lichen Planus	N/A
Completed	`NCT03858634` - A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases	Phase 2
Completed	`NCT02761122` - Implication of Human Papillomavirus (HPV) in Lichen Physiopathology in Human (HPVLichen)	N/A
Active, not recruiting	`NCT00691106` - A Multi-center Study to Evaluate the Safety of Etanercept in the Treatment of Lichen Planus	Phase 2
Terminated	`NCT05761158` - Study of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus Pilaris
Recruiting	`NCT02261662` - Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection	N/A
Not yet recruiting	`NCT04892381` - Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
Completed	`NCT05396261` - a Flexible Wound Dressing for the Management of Genital Skin Conditions	N/A
Recruiting	`NCT06327620` - Treatment Of Oral Lichen Planus	N/A
Completed	`NCT03796806` - Methods Validation Assessment for Study of Inflammatory Skin Disease
Completed	`NCT02850601` - Dexamethasone Solution for the Treatment of Oral Lichen Planus	Phase 2
Not yet recruiting	`NCT01041625` - Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus	Phase 2
Completed	`NCT00824889` - Exploratory Study of Natural Killer Cells in Human Skin	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms